Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
06/2010
06/02/2010CN101717377A Method for large-scale high-pressure synthesis of MBT as rubber vulcanization accelerator
06/02/2010CN101717376A Method for directly extracting and purifying rubber vulcanization accelerator MBT granules by methylbenzene
06/02/2010CN101717375A Method for synthesizing 2-Mercaptobenzothiazole (MBT) as rubber vulcanization accelerator by heat transfer oil
06/02/2010CN101717374A Compound comprising fork biphenyl center and preparation method thereof
06/02/2010CN101717373A Diaryl urea derivative and application thereof
06/01/2010US7728127 Cross-linked glycopeptide-cephalosporin antibiotics
06/01/2010US7728027 reacting 2-bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone with 1-(tert-butoxycarbonyl)-L-proline, then treating the product with ammonium acetate and deprotection to form chemical intermediates for viricides; cost efficiency; industrial scale
06/01/2010US7728019 Biphenylcarboxamides
06/01/2010US7728011 Dermally applicable liquid formulations for controlling parasitic insects on animals
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727979 Guanidine derivatives and their use as neuropeptide FF receptor antagonists
05/2010
05/27/2010WO2010058995A1 Electroluminescent device using the electroluminescent compounds
05/27/2010WO2010058402A1 Novel anti-biofilm agents
05/27/2010WO2010058314A1 Hydroxyquinolin-2(1h)-ones and derivatives thereof
05/27/2010WO2010011926A3 A novel betaine cocrystal of epalrestat
05/27/2010US20100130737 Regulating Agent of GPR34 Receptor Function
05/27/2010US20100130570 Fungicide n-5-membered fused heteroaryl-methylene-n-cycloalkyl-carboxamide derivatives
05/27/2010US20100130569 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
05/27/2010US20100130538 Bicyclic compound and pharmaceutical use thereof
05/27/2010US20100130490 Csf-1r inhibitors,compositions, and methods of use
05/27/2010US20100130446 Nitrogen-containing five-membered heterocyclic compound
05/26/2010EP2188274A1 Viral polymerase inhibitors
05/26/2010EP2188272A2 Phenyl- and benzylthiazolylpiperazine derivatives for the treatment of neurodegenerative diseases
05/26/2010EP2188262A1 Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain
05/26/2010EP2188261A1 Therapeutic compounds
05/26/2010EP2188260A1 Therapeutic quinoline and naphthalene derivatives
05/26/2010EP2188254A1 Novel bradykinin b1-antagonists
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN1671380B Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
05/26/2010CN1631144B Biocidal composition and its use
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/26/2010CN1359390B Factor VII a inhibitors
05/26/2010CN101715443A synthesis of chirally purified substituted benzothiazole diamines
05/26/2010CN101712657A heteroarylcarbamoylbenzene derivative
05/26/2010CN101007792B Synthesis process of nitro thiazoly benzamide compound
05/25/2010US7723553 organic electroluminescent device; flat-panel displays
05/25/2010US7723519 high binding efficiencies between D3 and D2 dopaminergic receptor subtypes; drug abuse, drug dependence
05/25/2010US7723380 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV.
05/25/2010US7723366 Cardiovascular disorders; antidiabetic agents; anticancer agents
05/25/2010CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials
05/20/2010WO2010056585A2 Heteroaryl diamide compounds useful as mmp-13 inhibitors
05/20/2010US20100125075 Antibacterial Agents
05/20/2010US20100124543 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
05/20/2010CA2743146A1 Heteroaryl diamide compounds useful as mmp-13 inhibitors
05/19/2010EP2186811A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
05/19/2010EP2186803A2 Substituted thioacetamides
05/19/2010EP2185503A1 Monoamide derivatives as orexin receptor antagonists
05/19/2010EP1575575B1 Safe chemical uncouplers for the treatment of obesity
05/19/2010CN101711238A 1, 3 - dihydroxy substituted phenylamide glucokinase activators
05/18/2010US7718682 3-(3,5-Dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylamide useful for therapy of inflammation, inflammatory bowl disease, psoriasis, rheumatic arthritis, dematitis and cardiovascular disorders; inhibiting the activity of TNF-alpha, IL-1, IL-6, or COX
05/18/2010US7718675 Diamino alcohols and their use as renin inhibitor
05/14/2010WO2010053218A1 Fluorinated benzothiazole derivatives, preparation method thereof and imaging agent for diagnosing altzheimer's disease using the same
05/13/2010US20100120876 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) compound or a melanocortin-4 receptor (mc4) agonist peptide
05/13/2010US20100120875 Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis
05/13/2010US20100120874 Heterocyclic gamma secretase modulators
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/13/2010US20100120784 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/12/2010EP2184285A1 Heterocyclic compound and use thereof
05/12/2010EP2184280A1 Substituted oxyguanidines
05/12/2010EP2184279A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
05/12/2010EP2183233A1 Dithiazolidine and thiazolidine derivatives as anticancer agents
05/12/2010EP2183232A2 Pi3 kinase modulators and methods of use
05/12/2010EP2183231A2 Predictive intelligence
05/12/2010EP2183222A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
05/12/2010EP2183215A2 Imidate compound and use thereof for pest control
05/12/2010EP2183213A2 Optically active (r)-aryloxypropionic acid amides and herbicidal composition comprising same
05/12/2010EP1173169B1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
05/12/2010CN1642929B Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative
05/12/2010CN101704798A Improved method for preparing benzoyl amide derivative
05/12/2010CN101704797A compounds effecting glucokinase
05/12/2010CN101139325B 2-(3-cyano-4-isobuoxy phenyl)4-methyl-5-thiazole aminic acid crystal and preparation method thereof
05/11/2010US7714141 Processes for production of optically active PPAR-activating compounds and intermediates for production thereof
05/11/2010US7714115 18-F labelled positron emission tomography tracer compounds such as [18F]-fluorodeoxyglucose; autoclaving; microfluidics; solid phase synthesis; solution phase synthesis
05/11/2010US7714004 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
05/11/2010US7713968 Substituted arylcyclopentenes as therapeutic agents
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010US7713962 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and/or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination
05/11/2010US7713931 Cross-linked glycopeptide-cephalosporin antibiotics
05/11/2010CA2399089C Process for exchanging functional groups by halogen-metal exchange reaction
05/11/2010CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050577A1 Cyclohexane derivative and pharmaceutical use thereof
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010008729A3 Process for making substituted 2-amino-thiazolones
05/06/2010WO2008125230A3 Insecticidal derivatives of substituted aminoheterocycles
05/06/2010US20100113770 O-substituted hydroxyaryl derivatives
05/06/2010US20100113540 Azole and Thiazole Derivatives and Their Use
05/06/2010US20100113539 Compounds for treating ophthalmic diseases and disorders
05/06/2010US20100113538 N-hydroxy-4- benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
05/06/2010US20100113531 Thiazolidine derivatives as orexin receptor antagonists
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/06/2010US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
05/06/2010US20100113305 Oxazole and thiazole combinatorial libraries
05/06/2010US20100113276 Use of n2-phenylamidines as herbicides
05/06/2010CA2739883A1 Cyclohexane derivative and pharmaceutical use thereof
05/05/2010EP2181987A1 Heterocyclic compound and use thereof
05/05/2010EP2181101A2 Tubulysin d analogues
05/05/2010EP2181097A1 Novel microbiocides
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 337